MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma : current status and future prospects
Hepatocellular carcinoma (HCC) remains to be one of the top causing cancer-related deaths today. The majority of HCC cases are reported to be the result of chronic hepatitis B virus (HBV) infection. Current treatments for HBV-related HCC revolve around the use of drugs to inhibit viral replication,...
Saved in:
Main Authors: | , |
---|---|
其他作者: | |
格式: | Article |
語言: | English |
出版: |
2015
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/107199 http://hdl.handle.net/10220/25366 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Nanyang Technological University |
語言: | English |